Keywords: roche, rise, net, income, beats, forecasts, boosted

Roche's 2007 25% rise in net income beats forecasts, boosted by cancer drugs

Article | 04 February 2008

Print This

2007 was a very good year for Swiss drug major Roche, which achieved 10% sales growth to 46.1 billion Swiss francs ($42.34 billion), with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in